ZURICH (Reuters) - - Swiss drugmaker Roche Holding AG is buying Constitution Medical Investors (CMI), the U.S. developer of a testing system for blood diseases like anemia and leukemia, for an upfront $220 million, plus further contingent payments. Roche, the world’s largest maker of cancer…
Source: Roche buys U.S. blood-testing firm for initial $220 million
Tuesday, July 2, 2013
Roche buys U.S. blood-testing firm for initial $220 million
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment